This site is intended for healthcare professionals
  • Home
  • /
  • Clinical trials
  • /
  • Uncategorised Disease
  • /
  • Trabectedin First Line Therapy In Unfit Sarcoma St...
Clinical trial

Trabectedin First Line Therapy In Unfit Sarcoma Study (TR1US)

Read time: 1 mins
Last updated:13th Feb 2014

Phase II, non-randomized, two-stage study according to Bryant & Day The study enroll patients with Metastatic and locally advanced soft tissue sarcoma unfit to receive standard chemotherapy (doxorubicin/epirubicin and/or ifosfamide)

Category Value
Study start date 2014-02-13

View full details